financetom
Business
financetom
/
Business
/
MCA to probe alleged fund diversions by Reliance Capital, Reliance Home Finance, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MCA to probe alleged fund diversions by Reliance Capital, Reliance Home Finance, says report
Jul 17, 2019 12:55 AM

The Ministry of Corporate Affairs (MCA) has started probing an alleged fund diversion by Reliance Capital and Reliance Home Finance, reported The Economic Times, citing sources close to the development. that the ministry is looking into suspicious transactions between the two firms and other companies belonging to the group, the report added.

The ministry, according to the report, will question the management and the audit committees of both the firms. In addition, the current auditor of the companies Pathak HD & Associates and PwC, executives who worked on the audit assignment, will also be questioned by the ministry, noted the report.

The investigation will be led by the ministry’s investigation arm Serious Fraud Investigation Office (SFIO), the report added.

Earlier, Price Waterhouse & Co Chartered Accountants LLP (PwC) resigned as one of the statutory auditors of Reliance Capital and Reliance Home Finance back in June. This, in turn, prompted Sebi and the Ministry of Corporate Affairs to look into the sudden resignation.

This was particularly significant in the wake of the auditors' role coming under the scanner of multiple agencies in cases involving various corporate houses, including listed companies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada's Trade War Economics Laid Bare With The Latest Data, Says TD
Canada's Trade War Economics Laid Bare With The Latest Data, Says TD
Sep 2, 2025
07:17 AM EDT, 09/02/2025 (MT Newswires) -- As summer winds down, last week's economic calendar heated up in Canada, said TD. The headline release was Q2 gross domestic product, offering the first hard look at how Canada's economy coped under the weight of tariffs, noted the bank. The economy contracted 1.6% quarter-over-quarter annualized -- in line with both TD's own...
BRIEF-Black Rock Coffee Bar IPO Price Per Share Of Class A Common Stock Expected Between $16.00-$18.00
BRIEF-Black Rock Coffee Bar IPO Price Per Share Of Class A Common Stock Expected Between $16.00-$18.00
Sep 2, 2025
Sept 2 (Reuters) - Black Rock Coffee Bar: * BLACK ROCK COFFEE BAR - SEES IPO OF 14,705,882 CLASS A COMMON STOCK - SEC FILING * BLACK ROCK COFFEE BAR - IPO PRICE PER SHARE OF CLASS A COMMON STOCK EXPECTED BETWEEN $16.00 AND $18.00 - SEC FILING * BLACK ROCK COFFEE BAR - WELLINGTON MANAGEMENT INDICATED INTEREST IN PURCHASING...
Nano Nuclear Energy Wins $1.3 Million Air Force Contract for Kronos MMR Energy System
Nano Nuclear Energy Wins $1.3 Million Air Force Contract for Kronos MMR Energy System
Sep 2, 2025
07:16 AM EDT, 09/02/2025 (MT Newswires) -- Nano Nuclear Energy ( NNE ) said Tuesday that it won a contract valued at about $1.3 million to explore the feasibility of deploying its advanced Kronos MMR Energy System at Joint Base Anacostia-Bolling or JBAB, a military base in Washington, D.C. The company said the AFWERX, the innovation and venture division of...
Merck Says Enlicitide Met Primary and Secondary Endpoints in Hypercholesterolemia Study
Merck Says Enlicitide Met Primary and Secondary Endpoints in Hypercholesterolemia Study
Sep 2, 2025
07:16 AM EDT, 09/02/2025 (MT Newswires) -- Merck & Co ( MRK ) said Tuesday its investigational oral PCSK9 inhibitor enlicitide decanoate met all primary and key secondary endpoints in adults with hypercholesterolemia in CORALreef lipids study. The company said that the treatment with enlicitide resulted in statistically significant and clinically meaningful reduction in low-density lipoprotein cholesterol compared with placebo...
Copyright 2023-2026 - www.financetom.com All Rights Reserved